<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>COX-2 is a major regulator implicated in <z:e sem="disease" ids="C0007102" disease_type="Neoplastic Process" abbrv="">colonic cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, how COX-2 signaling affects colonic <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> at cellular level is not clear </plain></SENT>
<SENT sid="2" pm="."><plain>In this article, we investigated whether activation of COX-2 signaling by <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> (DCA) in primary human <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated fibroblasts play a significant role in regulation of proliferation and invasiveness of colonic epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Our results demonstrated while COX-2 signaling can be activated by DCA in both <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated fibroblasts, the level of activation of COX-2 signaling is significantly greater in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated fibroblasts than that in <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we discovered that the proliferative and invasive potential of colonic epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells were much greater when the cells were co-cultured with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated fibroblasts pre-treated with DCA than with <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts pre-treated with DCA </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, COX-2 siRNA attenuated the proliferative and invasive effect of both <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associate fibroblasts pre-treated with DCA on the <z:e sem="disease" ids="C0007102" disease_type="Neoplastic Process" abbrv="">colonic cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Further studies indicated that the activation of COX-2 signaling by DCA is through protein kinase C signaling </plain></SENT>
<SENT sid="7" pm="."><plain>We speculate that activation of COX-2 signaling especially in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated fibroblasts promotes progression of <z:e sem="disease" ids="C0007102" disease_type="Neoplastic Process" abbrv="">colonic cancer</z:e> </plain></SENT>
</text></document>